{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:56Z","timestamp":1793084576817,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51690-w","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:56:01Z","timestamp":1779540961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of clinical pharmacist interventions on drug-related problems in hospitalised patients with renal dysfunction: a quasi-experimental study"],"prefix":"10.1038","volume":"16","author":[{"given":"\u00d6zge","family":"\u00d6zmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-9957","authenticated-orcid":false,"given":"Muhammed Yunus","family":"Bektay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cumali","family":"Karatoprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret Vehbi","family":"\u0130zzettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"51690_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/S12877-020-1413-7","author":"BY Hailu","year":"2020","unstructured":"Hailu, B. Y., Berhe, D. F., Gudina, E. K., Gidey, K. & Getachew, M. Drug related problems in admitted geriatric patients: The impact of clinical pharmacist interventions. BMC. Geriatr. https:\/\/doi.org\/10.1186\/S12877-020-1413-7 (2020).","journal-title":"BMC. Geriatr."},{"key":"51690_CR2","unstructured":"World Health Organisation. (2025). Medication Without Harm. https:\/\/www.who.int\/initiatives\/medication-without-harm"},{"key":"51690_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/S12882-023-03437-2","author":"J Kyomya","year":"2023","unstructured":"Kyomya, J., Atwiine, F., Shegena, E. A., Muhindo, R. & Yadesa, T. M. Drug-related problems and associated factors among patients with kidney dysfunction at a tertiary hospital in southwestern Uganda: A prospective observational study. BMC. Nephrol. https:\/\/doi.org\/10.1186\/S12882-023-03437-2 (2023).","journal-title":"BMC. Nephrol."},{"issue":"3","key":"51690_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3897\/PHARMACIA.68.E65136","volume":"68","author":"NM Susilawati","year":"2021","unstructured":"Susilawati, N. M., Halimah, E. & Saidah, S. Pharmacists\u2019 strategies to detect, resolve, and prevent DRPs in CKD patients. Pharmacia (Sofia). 68(3), 619\u2013626. https:\/\/doi.org\/10.3897\/PHARMACIA.68.E65136 (2021).","journal-title":"Pharmacia (Sofia)."},{"key":"51690_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/S12877-023-04557-Y","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions. BMC Geriatr. https:\/\/doi.org\/10.1186\/S12877-023-04557-Y (2023).","journal-title":"BMC Geriatr."},{"key":"51690_CR6","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2147\/IJGM.S462135","volume":"17","author":"HS Alqashqri","year":"2024","unstructured":"Alqashqri, H. S. et al. Prescribing renally inappropriate medication to hospitalized geriatric patients in Makkah, Saudi Arabia. Int. J. Gen. Med. 17, 1755. https:\/\/doi.org\/10.2147\/IJGM.S462135 (2024).","journal-title":"Int. J. Gen. Med."},{"issue":"4","key":"51690_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/JGS.14809","volume":"65","author":"M D\u00f6rks","year":"2017","unstructured":"D\u00f6rks, M., Allers, K., Schmiemann, G., Herget-Rosenthal, S. & Hoffmann, F. Inappropriate medication in non-hospitalized patients with renal insufficiency: A systematic review. J. Am. Geriatr. Soc. 65(4), 853\u2013862. https:\/\/doi.org\/10.1111\/JGS.14809 (2017).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"51690_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/1319-2442.318512","volume":"32","author":"BY Alqurashi","year":"2021","unstructured":"Alqurashi, B. Y., Elsamadisi, P. S., Aseeri, M. A. & Ismail, S. E. The impact of role of pharmacists in renal dosage adjustment program on renal drug dosing errors: A quasi-experimental study. Saudi J. Kidney Dis. Transpl. 32(1), 111\u2013117. https:\/\/doi.org\/10.4103\/1319-2442.318512 (2021).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"6","key":"51690_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/S40266-014-0172-6","volume":"31","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, D. et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 31(6), 471\u2013481. https:\/\/doi.org\/10.1007\/S40266-014-0172-6 (2014).","journal-title":"Drugs Aging."},{"issue":"3","key":"51690_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11096-006-9020-z","volume":"28","author":"HS Blix","year":"2006","unstructured":"Blix, H. S., Viktil, K. K., Moger, T. A. & Reikvam, \u00c5. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm. World Sci. 28(3), 152\u2013158. https:\/\/doi.org\/10.1007\/s11096-006-9020-z (2006).","journal-title":"Pharm. World Sci."},{"issue":"4","key":"51690_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7399\/fh.2015.39.4.8329","volume":"39","author":"E Delgado-Silveira","year":"2015","unstructured":"Delgado-Silveira, E. et al. The impact of pharmacy intervention on the treatment of elderly multi-pathological patients. Farm. Hosp. 39(4), 192\u2013202. https:\/\/doi.org\/10.7399\/fh.2015.39.4.8329 (2015).","journal-title":"Farm. Hosp."},{"key":"51690_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/S12875-025-02926-7","author":"MY Bektay","year":"2025","unstructured":"Bektay, M. Y., Ayhan, Y. E., \u00c7akmak, M. & Mercumek, B. Identification and evaluation of drug-related problems in community pharmacy in Turkey: A descriptive prevalence study. BMC. Prim. Care. https:\/\/doi.org\/10.1186\/S12875-025-02926-7 (2025).","journal-title":"BMC. Prim. Care."},{"key":"51690_CR13","unstructured":"Pharmaceutical Care Network Europe Association; PCNE. (2020). Classification for Drug related problems. https:\/\/www.pcne.org\/upload\/files\/417_PCNE_classification_V9-1_final.pdf"},{"key":"51690_CR14","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO). (2024). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. https:\/\/doi.org\/10.1016\/S0085-2538(24)00110-8","DOI":"10.1016\/S0085-2538(24)00110-8"},{"issue":"7748","key":"51690_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/BMJ.C332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ (Clin. Res. Ed.) 340(7748), 698\u2013702. https:\/\/doi.org\/10.1136\/BMJ.C332 (2010).","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"51690_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1049289","volume":"13","author":"MY Bektay","year":"2022","unstructured":"Bektay, M. Y., Sancar, M., Okyaltirik, F., Durdu, B. & Izzettin, F. V. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial. Front. Pharmacol. 13, 1049289. https:\/\/doi.org\/10.3389\/fphar.2022.1049289 (2022).","journal-title":"Front. Pharmacol."},{"key":"51690_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.49111","author":"H AlQashqri","year":"2023","unstructured":"AlQashqri, H. Renally inappropriate medications in the old population: prevalence, risk factors, adverse outcomes, and potential interventions. Cureus https:\/\/doi.org\/10.7759\/CUREUS.49111 (2023).","journal-title":"Cureus"},{"key":"51690_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2012-002068","author":"H Joosten","year":"2013","unstructured":"Joosten, H. et al. Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: Improving drug safety in primary healthcare by low eGFR alerts. BMJ Open https:\/\/doi.org\/10.1136\/BMJOPEN-2012-002068 (2013).","journal-title":"BMJ Open"},{"issue":"1","key":"51690_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/EJHPHARM-2017-001300","volume":"26","author":"PA Pou","year":"2019","unstructured":"Pou, P. A., Aquerreta Gonzalez, I., Idoate Garc\u00eda, A. & Garcia-Fernandez, N. Improvement of drug prescribing in acute kidney injury with a nephrotoxic drug alert system. Eur. J. Hosp. Pharm. 26(1), 33\u201338. https:\/\/doi.org\/10.1136\/EJHPHARM-2017-001300 (2019).","journal-title":"Eur. J. Hosp. Pharm."},{"key":"51690_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/IJCP.12960","author":"WH Tesfaye","year":"2017","unstructured":"Tesfaye, W. H., Castelino, R. L., Wimmer, B. C. & Zaidi, S. T. R. Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions. Int. J. Clin. Pract. https:\/\/doi.org\/10.1111\/IJCP.12960 (2017).","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"51690_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.18553\/JMCP.2016.22.8.959","volume":"22","author":"ML Davis-Ajami","year":"2016","unstructured":"Davis-Ajami, M. L., Fink, J. C. & Wu, J. Nephrotoxic medication exposure in U.S. adults with predialysis chronic kidney disease: Health services utilization and cost outcomes. J. Manag. Care Spec. Pharm. 22(8), 959\u2013968. https:\/\/doi.org\/10.18553\/JMCP.2016.22.8.959 (2016).","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"2","key":"51690_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/S11096-020-00982-W","volume":"42","author":"A Khokhar","year":"2020","unstructured":"Khokhar, A. et al. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study. Int. J. Clin. Pharm. 42(2), 625\u2013634. https:\/\/doi.org\/10.1007\/S11096-020-00982-W (2020).","journal-title":"Int. J. Clin. Pharm."},{"key":"51690_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-022-15657-X","author":"M Stuhec","year":"2022","unstructured":"Stuhec, M. & Zorjan, K. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci. Rep. https:\/\/doi.org\/10.1038\/S41598-022-15657-X (2022).","journal-title":"Sci. Rep."},{"key":"51690_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/S12913-022-08505-1","author":"F Zheng","year":"2022","unstructured":"Zheng, F., Wang, D. & Zhang, X. The impact of clinical pharmacist-physician communication on reducing drug-related problems: A mixed study design in a tertiary teaching hospital in Xinjiang, China. BMC Health Serv. Res. https:\/\/doi.org\/10.1186\/S12913-022-08505-1 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"51690_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-017-0585-5","author":"N Abunahlah","year":"2018","unstructured":"Abunahlah, N., Elawaisi, A., Velibeyoglu, F. M. & Sancar, M. Drug related problems identified by clinical pharmacist at the internal medicine ward in Turkey. Int. J. Clin. Pharm. https:\/\/doi.org\/10.1007\/s11096-017-0585-5 (2018).","journal-title":"Int. J. Clin. Pharm."},{"issue":"1","key":"51690_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-022-07494-5","volume":"22","author":"A Albayrak","year":"2022","unstructured":"Albayrak, A., Ba\u015fgut, B., B\u0131kmaz, G. A. & Karahalil, B. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. BMC Health Serv. Res. 22(1), 1\u20137. https:\/\/doi.org\/10.1186\/s12913-022-07494-5 (2022).","journal-title":"BMC Health Serv. Res."},{"issue":"11","key":"51690_CR27","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/jcpt.13784","volume":"47","author":"YE Ayhan","year":"2022","unstructured":"Ayhan, Y. E., Karakurt, S. & Sancar, M. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study. J. Clin. Pharm. Ther. 47(11), 1867\u20131874. https:\/\/doi.org\/10.1111\/jcpt.13784 (2022).","journal-title":"J. Clin. Pharm. Ther."},{"key":"51690_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/JCM10081788","author":"YK Song","year":"2021","unstructured":"Song, Y. K. et al. Effectiveness of clinical pharmacist service on drug-related problems and patient outcomes for hospitalized patients with chronic kidney disease: A randomized controlled trial. J. Clin. Med. https:\/\/doi.org\/10.3390\/JCM10081788 (2021).","journal-title":"J. Clin. Med."},{"key":"51690_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/S12913-022-08897-0","author":"HT Cheng","year":"2022","unstructured":"Cheng, H. T. et al. The prevalence of chronic medication therapy problems and pharmacists\u2019 interventions among hospitalized perioperative patients: A retrospective observational study. BMC. Health Serv. Res. https:\/\/doi.org\/10.1186\/S12913-022-08897-0 (2022).","journal-title":"BMC. Health Serv. Res."},{"issue":"2","key":"51690_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s11096-020-00992-8","volume":"42","author":"RM Umar","year":"2020","unstructured":"Umar, R. M., Apikoglu-Rabus, S. & Yumuk, P. F. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients. Int. J. Clin. Pharm. 42(2), 652\u2013661. https:\/\/doi.org\/10.1007\/s11096-020-00992-8 (2020).","journal-title":"Int. J. Clin. Pharm."},{"issue":"11","key":"51690_CR31","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.5005\/JP-JOURNALS-10071-23919","volume":"25","author":"M Aghili","year":"2021","unstructured":"Aghili, M. & Kasturirangan, M. N. Management of drug-drug interactions among critically ill patients with chronic kidney disease: Impact of clinical pharmacist\u2019s interventions. Indian J. Crit. Care Med. 25(11), 1226\u20131231. https:\/\/doi.org\/10.5005\/JP-JOURNALS-10071-23919 (2021).","journal-title":"Indian J. Crit. Care Med."},{"key":"51690_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2024.1473719","author":"B \u00d6zgan","year":"2024","unstructured":"\u00d6zgan, B., Ayhan, Y. E., Apikoglu, S. & Karakurt, S. Clinical pharmacist interventions in nutrition-and drug-related problems in critically ill patients with renal dysfunction: a non-randomized controlled study. Front. Med. https:\/\/doi.org\/10.3389\/FMED.2024.1473719 (2024).","journal-title":"Front. Med."},{"issue":"6","key":"51690_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/S11096-015-0175-3","volume":"37","author":"H Holm","year":"2015","unstructured":"Holm, H., Bjerke, K., Holst, L. & Mathiesen, L. Use of renal risk drugs in patients with renal impairment. Int. J. Clin. Pharm. 37(6), 1136\u20131142. https:\/\/doi.org\/10.1007\/S11096-015-0175-3 (2015).","journal-title":"Int. J. Clin. Pharm."},{"issue":"4","key":"51690_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/JAC5.1230","volume":"3","author":"D Cheung","year":"2020","unstructured":"Cheung, D., Go, A., Cooper, M. & Schwarz, K. Evaluation of a pharmacist-driven renal dosing protocol at an academic medical center. JACCP J. Am. Coll. Clin. Pharm. 3(4), 736\u2013742. https:\/\/doi.org\/10.1002\/JAC5.1230 (2020).","journal-title":"JACCP J. Am. Coll. Clin. Pharm."},{"issue":"11","key":"51690_CR35","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2215\/CJN.00580118","volume":"13","author":"CF Whittaker","year":"2018","unstructured":"Whittaker, C. F., Miklich, M. A., Patel, R. S. & Fink, J. C. Medication safety principles and practice in CKD. Clin. J. Am. Soc. Nephrol. 13(11), 1738\u20131746. https:\/\/doi.org\/10.2215\/CJN.00580118 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"51690_CR36","first-page":"431","volume":"114","author":"L O\u2019mahony","year":"2021","unstructured":"O\u2019mahony, L., Duffy, E., Mc Ginnity, M., Balmer, F. & Duffy, I. NSAIDs and renal impairment: deprescribing chronic NSAID use in general practice. Ir. Med. J. 114(8), 431 (2021).","journal-title":"Ir. Med. J."},{"key":"51690_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/S12882-024-03902-6","author":"G Mohammadnezhad","year":"2024","unstructured":"Mohammadnezhad, G. et al. Chronic kidney disease and adherence improvement program by clinical pharmacist-provided medication therapy management; a quasi-experimental assessment of patients\u2019 self-care perception and practice. BMC Nephrol. https:\/\/doi.org\/10.1186\/S12882-024-03902-6 (2024).","journal-title":"BMC Nephrol."},{"key":"51690_CR38","doi-asserted-by":"publisher","unstructured":"Demirhan, \u015e., Bektay, M. Y., \u015eekerci, A. & \u0130zzettin, F. V. Impact of structured patient education provided by clinicalpharmacist on disease prognosis, adherence and quality of life in Type 2 Diabetes patients: An interventional study.Acta Pharm. Sci. 62, 660\u2013677 https:\/\/doi.org\/10.23893\/1307-2080.APS6242 (2024).","DOI":"10.23893\/1307-2080.APS6242"},{"key":"51690_CR39","doi-asserted-by":"publisher","unstructured":"Kara, E., Kelleci \u00c7akir, B., Sancar, M. & Demirkan, K. Impact of Clinical Pharmacist-led Interventions in Turkey. Turk. J.Pharm. Sci. 18, 517\u2013526 https:\/\/doi.org\/10.4274\/TJPS.GALENOS.2020.66735 (2021).","DOI":"10.4274\/TJPS.GALENOS.2020.66735"},{"key":"51690_CR40","doi-asserted-by":"publisher","unstructured":"Kutluay, N. B., Bektay, M. Y., Sumbul-Sekerci, B., Sekerci, A. & Izzettin, F. V. Impact of clinical pharmacist integrationon diabetes management: a prospective cohort. BMC Health Serv. Res. 25, 1 https:\/\/doi.org\/10.1186\/S12913-025-12233-7 (2025).","DOI":"10.1186\/S12913-025-12233-7"},{"key":"51690_CR41","doi-asserted-by":"publisher","unstructured":"Pehlivanli, A., Eren-Sadioglu, R., Aktar, M., Eyupoglu, S., Sengul, S., Keven, K. et al. Potential drug-drug interactions ofimmunosuppressants in kidney transplant recipients: comparison of drug interaction resources. Int. J. Clin. Pharm. 44, 651\u2013662 https:\/\/doi.org\/10.1007\/s11096-022-01385-9 (2022).","DOI":"10.1007\/s11096-022-01385-9"},{"key":"51690_CR42","doi-asserted-by":"publisher","unstructured":"Pehlivanli, A., Eyupoglu, S., Basgut, B., Erturk, S. & Ozcelikay, A. T. Impact of a multidisciplinary approach involvingclinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study. BMC Nephrol. 24, 1 https:\/\/doi.org\/10.1186\/s12882-023-03210-5 (2023).","DOI":"10.1186\/s12882-023-03210-5"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51690-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:44:22Z","timestamp":1785451462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51690-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51690"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51690-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing \u0131nterests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Clinical Research Ethics Committee of Bezmialem Vak\u0131f University (decision number 18\/12). This study protocol has been retrospectively registered on 23\/11\/2025 at ClinicalTrials.gov (NCT07241494). All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and relevant national regulations governing research involving human participants. Patient confidentiality and data protection were strictly maintained throughout the study, and no identifiable personal information was disclosed at any stage. Written informed consent was obtained from all participants prior to enrolment in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23668"}}